|
LETM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.158200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.083000E-01 |
| Normal-vs-Stage2 |
7.596900E-04 |
| Normal-vs-Stage3 |
1.684630E-01 |
| Normal-vs-Stage4 |
3.634000E-01 |
| Stage1-vs-Stage2 |
2.236600E-04 |
| Stage1-vs-Stage3 |
5.398300E-02 |
| Stage1-vs-Stage4 |
2.158200E-01 |
| Stage2-vs-Stage3 |
4.27750000000504E-05 |
| Stage2-vs-Stage4 |
2.756100E-04 |
| Stage3-vs-Stage4 |
8.323600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.772400E-01 |
| Normal-vs-AfricanAmerican |
3.451600E-01 |
| Normal-vs-Asian |
3.666400E-01 |
| Caucasian-vs-AfricanAmerican |
2.938400E-01 |
| Caucasian-vs-Asian |
4.506200E-01 |
| AfricanAmerican-vs-Asian |
1.107590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.141800E-01 |
| Normal-vs-Female |
8.725000E-01 |
| Male-vs-Female |
3.128800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.743800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.194000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.022990E-01 |
| Normal-vs-Age(81-100Yrs) |
5.716600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.906600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.135610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.896200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.564100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.593200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.180600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.12890000014687E-07 |
| Classical-VS-Follicular |
3.41060000241811E-08 |
| Classical-VS-Other |
5.107800E-01 |
| Classical-VS-Normal |
8.318000E-01 |
| Tall-VS-Follicular |
1.22124532708767E-15 |
| Tall-VS-Other |
1.107980E-01 |
| Tall-VS-Normal |
2.56389999997442E-06 |
| Follicular-VS-Other |
1.809960E-02 |
| Follicular-VS-Normal |
3.10359999999843E-06 |
| Other-VS-Normal |
2.832800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.089900E-02 |
| Normal-vs-N1 |
6.442800E-03 |
| N0-vs-N1 |
2.25870000003514E-06 |
|
|
